Botfet / Company detail

PEN

universe

Penumbra, Inc.

biotech

Moat score60out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic9.9%

Gross Margin67.1%

Revenue Cagr17.1%

Fcf Conversion98.5%

Fcf Yield1.4%

Interest Coverage170.8x

Market Cap B$12.8B

Pe79.3

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant60

Why it may endure

Moat breakdown

Quant: 60 · Curator: 0

Market Share Stability12

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener